Article
Oral Gene III <sup>®</sup> L-Ergothioneine Capsules in Women with Suboptimal Ovarian Reserve: A Single-Center, Open-Label, Self-Controlled Pilot Study of Ovarian Reserve Markers, Endocrine Profiles, and Reproductive Aging-Related Symptoms
2026-04-04
Abstract excerpt
<h4>Purpose</h4> To evaluate the efficacy and safety of oral L-ergothioneine (EGT) in improving ovarian reserve and clinical symptoms in women with suboptimal ovarian function. As a proof-of-concept study, we explored correlations between hormonal shifts and symptom amelioration. <h4>Methods</h4> This single-center, open-label trial enrolled 40 women (aged 35–45 years) experiencing age-related reproductive decli...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fd4d2886-acb4-5652-a2d6-630e052e0fd6
- DOI
- 10.64898/2026.04.02.26350093
